20 Jun, EOD - Indian

Nifty 50 25112.4 (1.29)

Nifty Next 50 66733.05 (1.34)

Nifty Bank 56252.85 (1.22)

Nifty Pharma 21613 (0.80)

SENSEX 82408.17 (1.29)

Nifty Midcap 100 57995.5 (1.46)

Nifty IT 38991.45 (0.84)

Nifty Smallcap 100 18194.2 (1.01)

20 Jun, EOD - Global

NIKKEI 225 38403.23 (-0.22)

HANG SENG 23530.48 (1.26)

S&P 6037 (-0.15)


Mid Session News

You are Here : Home > News > Mid Session News >

(19 Jun 2025, 10:35)

Benchmarks trade near flat line; IT shares tumble


The key domestic indices traded near flat line with positive bias in morning trade, despite ongoing escalating geopolitical tensions between Israel and Iran. Further impacting sentiment was the US Federal Reserve's decision to hold interest rates, with the central bank projecting elevated inflation and slower economic growth ahead. Market direction will likely continue to be shaped by these geopolitical developments, with investors closely tracking crude oil prices and broader global events. The Nifty traded above the 24,800 level.

IT shares declined for the second consecutive trading session.

At 10:25 IST, the barometer index, the S&P BSE Sensex advanced 45.01 points or 0.06% to 81,495.06. The Nifty 50 index rose 20.15 points or 0.08% to 24,832.75.

In the broader market, the S&P BSE Mid-Cap index fell 0.49% and the S&P BSE Small-Cap index shed 0.32%.

The market breadth was positive. On the BSE, 1,406 shares rose and 2,003 shares fell. A total of 211 shares were unchanged.

Buzzing Index:

The Nifty IT index fell 0.98% to 38,650.05. The index declined 1.79% for the two consecutive trading sessions.

Tech Mahindra (down 2.51%), LTIMindtree (down 2.24%), Oracle Financial Services Software (down 1.65%), Persistent Systems (down 1.52%), Mphasis (down 1.43%) Coforge (down 1.34%), Infosys (down 0.94%), HCL Technologies (down 0.64%) and Tata Consultancy Services (down 0.52%) declined.

Stocks in Spotlight:

Tata Elxsi fell 1.40%. The company announced that it has signed a memorandum of understanding (MoU) with Infineon Technologies to jointly develop application-ready EV solutions tailored to the Indian market.

Marksans Pharma fell 0.64%. The company announced that its wholly owned subsidiary Relonchem has received marketing authorization for the product Oxybutynin hydrochloride Oral Solution from UK Medicines & Healthcare Products Regulatory Agency (UKMHRA).

Puravankara rallied 3.16% after the company’s, wholly owned subsidiary, Starworth Infrastructure & Construction, received a letter of intent (LoI) worth Rs 272 crore from Tru Dwellings.

More News

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +